Use access key #2 to skip to page content.
$1.90 -0.36 (-15.93%)
10/7/2008 4:00 PM

Javelin Pharmaceuticals, Inc. (JAV)

CAPS Rating:
***

The Company is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.

View All Commentary (JAV)

Recs

0

Avatar Lennyg02 (< 20) Submitted: 5/10/08 3:28 PM : Outperform Start Price: $2.76 JAV Score: 10.72

Several pain medications in the works (and pain will not go away). One drug has been approved in Europe and is in Phase III in the US. Their intranasal morphine product seems interesting (also in Phase III).

Report this Post Replies: 0 | Reply

Featured Broker Partners